Chemours Valuation
| CC Stock | MXN 408.90 0.00 0.00% |
At this time, the firm appears to be fairly valued. Chemours shows a prevailing Real Value of 395.48 per share. The current price of the firm is 408.9. Our model approximates the value of Chemours from analyzing the firm fundamentals such as Profit Margin of 0.09 %, operating margin of 0.12 %, and Return On Equity of 0.53 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Chemours' price fluctuation is very steady at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 408.9 | Real 395.48 | Hype 408.9 |
The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chemours' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of The Chemours helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors: Chemours Total Value Analysis
The Chemours is currently expected to have takeover price of 146.34 B with market capitalization of 96.97 B, debt of 3.59 B, and cash on hands of 697 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Chemours fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
146.34 B | 96.97 B | 3.59 B | 697 M |
Chemours Investor Information
About 78.0% of the company shares are held by institutions such as insurance companies. The book value of Chemours was currently reported as 7.45. The company has Price/Earnings To Growth (PEG) ratio of 1.71. Chemours recorded earning per share (EPS) of 68.58. The entity last dividend was issued on the 23rd of February 2023. Based on the key indicators related to Chemours' liquidity, profitability, solvency, and operating efficiency, The Chemours is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Chemours Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Chemours has an asset utilization ratio of 88.93 percent. This suggests that the Company is making 0.89 for each dollar of assets. An increasing asset utilization means that The Chemours is more efficient with each dollar of assets it utilizes for everyday operations.Chemours Ownership Allocation
Chemours holds a total of 148.5 Million outstanding shares. The majority of The Chemours outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of The Chemours as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Chemours Profitability Analysis
The company reported the revenue of 6.79 B. Net Income was 578 M with profit before overhead, payroll, taxes, and interest of 1.62 B.About Chemours Valuation
Our relative valuation model uses a comparative analysis of Chemours. We calculate exposure to Chemours's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Chemours's related companies.The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in Mexico and is traded on Mexico Stock Exchange. It employs 7000 people.
8 Steps to conduct Chemours' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Chemours' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Chemours' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Chemours' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Chemours' revenue streams: Identify Chemours' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Chemours' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Chemours' growth potential: Evaluate Chemours' management, business model, and growth potential.
- Determine Chemours' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Chemours' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.